CL
Chronic Lymphocytic Leukemia Research
This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL). It covers topics such as the use of BTK inhibitors (e.g., Ibrutinib), the role of rituximab, TP53 mutations, and the impact of immunoglobulin mutations. Additionally, it explores therapeutic targets and outcomes in patients with Waldenström macroglobulinemia.
99,076
Publications
1,195,164
Citations
Loading papers...
Search by keywords
Filter by Type
- Article (204,671)
- Review (15,365)
- Letter (12,379)
- Preprint (8,079)
- Book Chapter (7,753)
Filter by Open Access Type
- Open Access (89,155)
- Closed Access (174,557)
Filter by Authors
- Hagop M. Kantarjian (1,793)
- Jörge E. Cortes (1,454)
- William G. Wierda (1,166)
- Michael J. Keating (988)
- Stephan Stilgenbauer (920)
Filter by Topics
- Chronic Lymphocytic Leukemia Research (263,712)
- Lymphoma Diagnosis and Treatment (76,580)
- Chronic Myeloid Leukemia Treatments (46,185)
- Immunodeficiency and Autoimmune Disorders (29,727)
- Acute Lymphoblastic Leukemia research (28,613)